Clinical Trial

Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry

Study acronym: PPHNet
Recruiting
View on ClinicalTrials.gov →
Summary
Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of the disease process will increase and lead to better treatment. Investigators believe that pulmonary hypertension in children is different than pulmonary hypertension in adults and this study will help us understand those differences.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2014-09-23; most recent amendment 2025-03-10.
Status change: Not Yet Recruiting → Recruiting 2015-03-02
Trial Details
NCT Number NCT02249923
Lead Sponsor New York Medical College
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), Janssen Pharmaceuticals
Conditions Pulmonary Vascular Disease, Pulmonary Arterial Hypertension
Enrollment 2,500 participants
Start Date 2014-10
Primary Completion 2030-12 (estimated)
Study Completion 2031-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-13